Finance of Fighting Cancer

This book dives deep into the financial side of cancer immunotherapy. It breaks down the costs of new treatments, comparing them to traditional methods. Inside, you'll find: Chapter 1: Economic overview of immunotherapy, including cost analyses, funding, and global impact. Chapter 2: The price of checkpoint inhibitors, financial aid, and long-term value. Chapter 3: CAR T-cell therapy expenses, from production to insurance. Chapter 4: Costs of developing cancer vaccines and their potential for prevention. Chapters 5-11: Financial analyses of various immunotherapies, including oncolytic viruses, adoptive cell transfer, bispecific antibodies, and nanotechnology. Chapter 12: Strategies to lower costs and improve global access to these life-saving treatments. Essential reading for healthcare financiers, policymakers, and anyone treating cancer.